Catalyst Wire Dossier Catalyst Wire Dossier

BUPHENYL

Sodium phenylbutyrate · Horizon Therapeutics USA, Inc.
Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for BUPHENYL, covering 2009-03-31 to 2022-07-29. Get the full timeline:

Most recent: FDA Approved: BUPHENYL — Supplemental Application (Horizon Therapeutics USA, Inc.)

See pricing